Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ray Kurzweil files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Martine A. Rothblatt - $801.69M in UTHR purchases and sales in the last 12 months
- James Edgemond - $201.52M in UTHR purchases and sales in the last 12 months
- Michael Benkowitz - $135.23M in UTHR purchases and sales in the last 12 months
- Paul A. Mahon - $98.96M in UTHR purchases and sales in the last 12 months
- Christopher Patusky - $2.73M in UTHR purchases and sales in the last 12 months
- Tommy G. Thompson - $2.06M in UTHR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ray Kurzweil?
Ray Kurzweil is a corporate insider of UNITED THERAPEUTICS Corp (UTHR). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ray Kurzweil submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Ray Kurzweil been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($2.40M) across all tracked filings.
